Blinklab Limited (AU:BB1) has released an update.
BlinkLab Limited (ASX: BB1) has requested a trading halt on its securities as it prepares to release an announcement concerning the FDA pre-submission outcome. The trading halt will continue until the announcement is made or normal trading resumes on December 20, 2024. This move has sparked interest among investors eager to learn the potential impact on the company’s market position.
For further insights into AU:BB1 stock, check out TipRanks’ Stock Analysis page.